MOTHER'S DAY SPECIALS! SHOW ME MORE

Close Notification

Your cart does not contain any items

$133.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Churchill Livingstone
30 August 2024
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.

Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both;

advantages of total body PET imaging in hematological malignancies; applications of FDG-PET imaging in leukemias; PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease; and more. Provides in-depth clinical reviews on novel PET imaging techniques in the management of hematological malignancies, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Edited by:   , , , , , , , , , ,
Imprint:   Churchill Livingstone
Country of Publication:   United Kingdom
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   450g
ISBN:   9780443246340
ISBN 10:   0443246343
Series:   The Clinics: Radiology
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas New PET Tracers for Lymphoma Radioligand Therapy in Lymphoma: Past, Present, and Future Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence New PET Tracers for Symptomatic Myeloma Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia Role of Novel Quantitative Imaging Techniques in Hematological Malignancies Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking

See Also